Allozymes leverages its proprietary microfluidics technology to revolutionize enzyme engineering, enabling the rapid development of novel enzymes that can significantly enhance the manufacturing of complex natural products. By utilizing a droplet-based platform, Allozymes can build and test millions of enzyme variants daily, increasing the likelihood of success in enzyme development by 200 times compared to traditional methods. This innovative approach allows for the creation of various enzyme types, including oxidases, reductases, isomerases, and hydrolases, at a pace that is ten times faster than conventional robotics technology. The efficiency of this platform not only accelerates product introduction but also supports the development of sustainable biosolutions that minimize environmental impact.

In addition to enzyme engineering, Allozymes is focused on expanding its capabilities to create complete biosynthetic solutions for the sustainable production of high-value specialty ingredients. The company aims to optimize enzyme specificity and product yield across various applications, including food and fine chemicals. By developing custom enzymes and processes, Allozymes is committed to upcycling waste materials and producing natural ingredients that contribute to a carbon-neutral economy. Their work exemplifies a shift towards cleaner, greener manufacturing methods that align with the growing demand for sustainable practices in industry.

Singapore

Allozymes is a fast-growing biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the bioeconomy across sectors. Leveraging this ultra-high screening power, Allozymes aims to build the largest enzyme data library in the world to address the current and future needs of building robust biosolutions.

79 Science Park Drive Suite 06-05, 118264

Allozymes

Company Details